Prescription drug · ANDA
Buprenorphine NDC 63629-9475
Buprenorphine hydrochloride 2 mg/1 · Tablet · Sublingual · Bryant Ranch Prepack
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 63629-9475-1 | 63629947501 | 30 TABLET in 1 BOTTLE (63629-9475-1)Marketed from Nov 28, 2022 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Buprenorphine
- Generic name (nonproprietary)
- buprenorphine
- Active ingredients
- Buprenorphine hydrochloride — 2 mg/1
- Dosage form
- Tablet
- Route
- Sublingual
- Labeler
- Bryant Ranch Prepack
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 207276
- Marketing start
- Listing expires
- DEA schedule
- CIII
- Other FDA classes
- Partial Opioid Agonists (Mechanism)
- Identifiers
- Product ID 63629-9475_e161bf41-8a6b-4226-a028-7935a8283063SPL ID e161bf41-8a6b-4226-a028-7935a8283063SPL set ID bc5a7137-9e8f-438e-84d9-bdbf1db12998RxCUI 351264UNII 56W8MW3EN1
- Pharmacologic class
- Partial Opioid Agonist
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Sublingual products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N463629947501followed by a unit qualifier and the quantityPackage 63629-9475-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Buprenorphine Sublingual Tablets are indicated for the treatment of opioid dependence and are preferred for induction. Buprenorphine sublingual tablets should be used as part of a complete treatment plan to include counseling and psychosocial support. Buprenorphine sublingual tablets contain buprenorphine, a partial opioid agonist, and are indicated for the treatment of opioid dependence and are preferred for induction. ( 1 ) Buprenorphine sublingual tablets should be used as part of a complete treatment plan that includes counseling and psychosocial support. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 207276
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | American Health Packaging | 60687-481 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 72162-1344 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Bryant Ranch Prepack | 72162-1345 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | American Health Packaging | 60687-492 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Bryant Ranch Prepack | 71335-0950 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Unit Dose Solutions, Inc. | 87441-011 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Unit Dose Solutions, Inc. | 87441-082 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Clinical Solutions Wholesale, LLC | 58118-0501 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Clinical Solutions Wholesale, LLC | 58118-0502 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Bryant Ranch Prepack | 71335-1154 |
| Buprenorphine | Buprenorphine hydrochloride 2 mg/1 | TabletSublingual | Rhodes Pharmaceuticals LLC | 42858-501 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | Rhodes Pharmaceuticals LLC | 42858-502 |
| Buprenorphine | Buprenorphine hydrochloride 8 mg/1 | TabletSublingual | A-S Medication Solutions | 50090-5805 |